Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

2011

4001 ARTíCULOS , VIENDO DEL 46 AL 60

PUBMED

Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.

Calahorro F, Ruiz-Rubio M.

Invert Neurosci. 2011 Dec;11(2):73-83. doi: 10.1007/s10158-011-0126-1. Review.

0

0

0

PUBMED

Symptoms of Parkinson's disease.

[No authors listed]

Nurs Older People. 2011 Oct 26;23(9):11.

0

0

0

PUBMED

Caffeine in Parkinson's disease: a pilot open-label, dose-escalation study.

Altman RD, Lang AE, Postuma RB.

Mov Disord. 2011 Nov;26(13):2427-31. doi: 10.1002/mds.23873.

0

0

0

PUBMED

Analysis of the substantia innominata volume in patients with Parkinson's disease with dementia, dementia with lewy bodies, and Alzheimer's disease.

Kim HJ, Lee JE, Shin SJ, Sohn YH, Lee PH.

J Mov Disord. 2011 Oct;4(2):68-72. doi: 10.14802/jmd.11014.

0

0

0

PUBMED

Imaging biomarkers in Parkinson's disease.

Brooks DJ, Pavese N.

Prog Neurobiol. 2011 Dec;95(4):614-28. doi: 10.1016/j.pneurobio.2011.08.009. Review.

0

0

0

PUBMED

Neurologist care in Parkinson disease: a utilization, outcomes, and survival study.

Willis AW, Schootman M, Evanoff BA, Perlmutter JS, Racette BA.

Neurology. 2011 Aug 30;77(9):851-7. doi: 10.1212/WNL.0b013e31822c9123.

0

0

0

PUBMED

Effect of rotigotine on sleep and quality of life in Parkinson's disease patients: post hoc analysis of RECOVER patients who were symptomatic at baseline.

Ghys L, Surmann E, Whitesides J, Boroojerdi B.

Expert Opin Pharmacother. 2011 Sep;12(13):1985-98. doi: 10.1517/14656566.2011.604031.

0

0

0

PUBMED

Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease.

McArthur S, Gillies GE.

Front Endocrinol (Lausanne). 2011 Nov 30;2:82. doi: 10.3389/fendo.2011.00082.

0

0

0

PUBMED

Highly potent activity of (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in animal models of Parkinson's disease.

Ardashov OV, Pavlova AV, Il'ina IV, Morozova EA, Korchagina DV, Karpova EV, Volcho KP, Tolstikova TG, Salakhutdinov NF.

J Med Chem. 2011 Jun 9;54(11):3866-74. doi: 10.1021/jm2001579.

0

0

0

PUBMED

On the role of fronto-striatal neural synchronization processes for response inhibition--evidence from ERP phase-synchronization analyses in pre-manifest Huntington's disease gene mutation carriers.

Beste C, Ness V, Falkenstein M, Saft C.

Neuropsychologia. 2011 Oct;49(12):3484-93. doi: 10.1016/j.neuropsychologia.2011.08.024.

0

0

0

PUBMED

Acute effects of bilateral subthalamic stimulation on decision-making in Parkinson's disease.

Oyama G, Shimo Y, Natori S, Nakajima M, Ishii H, Arai H, Hattori N.

Parkinsonism Relat Disord. 2011 Mar;17(3):189-93. doi: 10.1016/j.parkreldis.2010.12.004.

0

0

0

PUBMED

GSK3β polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort.

Kalinderi K, Fidani L, Katsarou Z, Clarimón J, Bostantjopoulou S, Kotsis A.

Neurobiol Aging. 2011 Mar;32(3):546.e1-5. doi: 10.1016/j.neurobiolaging.2009.05.007.

0

0

0

PUBMED

Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.

Chen LW, Kuang F, Wei LC, Ding YX, Yung KK, Chan YS.

CNS Neurol Disord Drug Targets. 2011 Jun;10(4):449-58. Review.

0

0

0

PUBMED

Co-segregation of Huntington disease and hereditary spastic paraplegia in 4 generations.

Panas M, Karadima G, Kalfakis N, Vassilopoulos D.

Neurologist. 2011 Jul;17(4):211-2. doi: 10.1097/NRL.0b013e3182173567.

0

0

0

PUBMED

Enhanced glutamate, IP3 and cAMP activity in the cerebral cortex of unilateral 6-hydroxydopamine induced Parkinson's rats: effect of 5-HT, GABA and bone marrow cell supplementation.

Nandhu MS, Paul J, Kuruvilla KP, Malat A, Romeo C, Paulose CS.

J Biomed Sci. 2011 Jan 15;18:5. doi: 10.1186/1423-0127-18-5.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy